Pharmaceutical Excipients Market: By Product (Inorganic Chemicals, Organic Chemicals, Petrochemicals), By Function (Fillers and Diluents, Coatings, Binders, Disintegrants, Flavouring Agents, Colorants), By Dosage Form (Tablets, Capsules, Liquids, Injections), By End User (Biotech Companies, Pharmaceutical Companies, Research Institutes) and Geography     

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Pharmaceutical Excipients Market size is expected to reach USD 10.8 billion by 2028 from USD 6.9 billion in 2021, at a CAGR of 6.1% during the forecast period 2022-28. Pharmaceutical excipients are combined with active pharmaceutical ingredients to produce the final dosage form of the drugs. The excipients provide bulkiness to formulation, facilitates absorption of the drug, provides stability and prevent from the drugs from denaturation. pharmaceutical excipients market are cost effective, stable, feasible for handling, and inert in the nature. The excipient is a material that has been tested for safety and is added to a medication delivery system. It is not an active pharmaceutical ingredient (API). The main functions of excipients are to protect, support, improve stability, bioavailability, patient acceptability, and aid in effectiveness. The market is made up of sales of pharmaceutical excipients and revenue earned by the company's manufacturing of these excipients. The major advantages of using excipients are improving property of wetting, increase bulkiness of drug, provides stability, and improves the organoleptic properties of the drug. Excipients are used in a different medicinal products like capsules, tablets, oral liquids, inhalers, implants and injections among others. Factors such as patient compliance and ease in consumption forcing drug manufactures in developing a sustained release dosage formulations which contributes to the extension of shelf life of the oral drugs that adds to the high revenue anticipation of pharmaceutical excipients. However, lack of standard quality policies and regulations for excipients and safety evaluation is expected to hamper the growth of the market over the forecast period. Key Developments: In June 2017, Ashland Inc. got US patent for purekote 23589 (dispersion) and purekote 21412a (cross linking agent) coating system In April 2017, Lubrizol Corporation’s Skin Essentials division launched new acrylate-based polymeric emulsifier Pemulen EZ-4U In July 2016, The Lubrizol Corporation acquired Diamond Dispersions Ltd to expand its product portfolio that enable digital painting

Global Pharmaceutical Excipients Market Summary

Study Period

2023-29

Base Year

2022

CAGR

6.1%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Pharmaceutical Excipients Market Dynamics

Global pharmaceutical excipients market is driven by growing demand for oral pharmaceuticals (solid) and development of novel therapeutics because of increase in pharmaceutical industries. The combination of nanotechnology and drug formulations in excipients led the development of nano-derived liposomes, vaccines, and nano coated tablets. The global pharmaceutical excipients market is expected to grow at a significant CAGR over the forecast period owing to increase in utilization of parenteral products, rise in the global burden of chronic & lifestyle diseases and increasing investments by the pharmaceutical industry on the development of biologics. Good manufacturing and distribution practices for for uniform excipients, spanning regions by international regulatory authorities is set to define the market landscape of the excipient industry over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Pharmaceutical Excipients Market Segmentation

By Product Type
  • Inorganic Chemicals
  • Organic Chemicals
  • Petrochemicals
By Function
  • Fillers and Diluents
  • Coatings
  • Binders
  • Disintegrants
  • Flavouring Agents
  • Colorants
  • Others
By Dosage Form
  • Tablets
  • Capsules
  • Liquids
  • Injections
  • Others
By End User
  • Biotech Companies,
  • Pharmaceutical Companies,
  • Research Institutes

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']
Some of the Key players operating in global pharmaceutical excipients market are Ashland Inc.(U.S.), AkzoNobel (Netherlands), The DOW Chemical Company (U.S.), Archer Daniels Midland Company(U.S.), Associated British Foods PLC (UK), Colorcon, Inc.(U.S.), BASF SE(Germany), Evonik Industries AG (Germany), Innophos Holdings Inc. (U.S.), J.M. Huber Corporation (U.S.), FMC Corporation (U.S.), Roquette Group (Nord-Pas de Calais), Croda International PLC (UK),Merck KGaA (U.S.) and Lubrizol Corporation (U.S.) to name a few.